id
related bits
0
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2024-02-16 18:22:42
expired found date
-
created at
2024-07-01 08:53:52
updated at
2025-11-08 11:51:54
length
17
crc
54415
tld
978
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
2
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
2025-07-11 03:26:46
server bits
LITESPEED
server ip
mp import status
20
mp rejected date
-
mp saved date
2025-10-26 02:23:28
mp size orig
58707
mp size raw text
4961
mp inner links count
9
mp inner links status
10 (links queued, awaiting import)
title
Ovarian Cancer Treatments and Diagnosis Research – DECIDER
description
Decider is a research project developing diagnostic tools and treatments for high-grade serous ovarian cancer with AI methods.
image
site name
DECIDER
author
updated
2026-03-04 22:40:10
raw text
Ovarian Cancer Treatments and Diagnosis Research – DECIDER Homepage Research Partners Publications Patients Blog Contact Homepage Research Partners Publications Patients Blog Contact DECIDER – Improving clinical decisions in cancer DECIDER (Clinical Decision via Integrating Multiple Data Levels to Overcome Chemotherapy Resistance in High-Grade Serous Ovarian Cancer) is a research project funded by the European Union from 1.2.2021 to 31.7.2026 under Horizon 2020 research and innovation programme under grant agreement No 965193. Main goals of DECIDER The mains goals of DECIDER are to develop diagnostic tools and treatments for high-grade serous ovarian cancer with the help of AI methods. The aim is to identify earlier those patients who do not respond well to the first-line treatments, and to find effective treatments to patients with a drug-resistant cancer. We also study the legal issues that impede or slow down the use of new treatments in order t...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
index version
1
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
3867
text words
702
text unique words
287
text lines
86
text sentences
33
text paragraphs
14
text words per sentence
21
text matched phrases
0
text matched dictionaries
0
links self subdomains
0
links other subdomains
0
links other domains
0
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
6 - twitter.com, linkedin.com
links ext klim
0
links ext generic
0
dol status
0
dol updated
2026-03-04 22:40:10
rss path
rss status
1 (priority 1 already searched, no matches found)
rss found date
-
rss size orig
0
rss items
0
rss spam phrases
0
rss detected language
0 (awaiting analysis)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
1 (priority 1 already searched, no matches found)
sitemap review version
1
sitemap urls count
0
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
-
sitemap process date
2024-07-01 08:53:53
sitemap first import date
-
sitemap last import date
-